Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.
Also called NCT03210532
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 129 participants
- Registry
-
NCT03210532
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03210532. Randomized; double masking; primary purpose treatment. Start 2016-10-07 (actual); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
- Condition
- Hypertension
- Condition
- Dyslipidemia
- Intervention (Drug)
- Telmisartan + Amlodipine + Rosuvastatin
- Intervention (Drug)
- Telmisartan + Amlodipine
- Intervention (Drug)
- Telmisartan + Rosuvastatin
- Lead sponsor
- Daewon Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct03210532- Content hash
5c726594682159f65ba533ecd68f415c3416c6ce695bbc50f9dc7c73b3937737